Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong performance has led Novonesis to now expect full-year organic sales growth to be at the upper end of the 7-8% range, and the adjusted EBITDA margin is confirmed to be between 35.5-36.5%.
GlobeNewswire,is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Latest posts by GlobeNewswire (see all)
- Lori Lane Leads Berkshire Hathaway HomeServices Georgia Properties’ New Homes Division to Triumph at 44th OBIE Awards - December 7, 2024
- AIXI DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Secure Counsel Before Important December 16 Deadline in Securities Class Action – AIXI - December 7, 2024
- icebreaker and Protect Our Winters Partner to Support Glacier Conservation - December 6, 2024
